These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 26648032)
21. Sequestration of chaperones and proteasome into Lafora bodies and proteasomal dysfunction induced by Lafora disease-associated mutations of malin. Rao SN; Maity R; Sharma J; Dey P; Shankar SK; Satishchandra P; Jana NR Hum Mol Genet; 2010 Dec; 19(23):4726-34. PubMed ID: 20858601 [TBL] [Abstract][Full Text] [Related]
22. Laforin targets malin to glycogen in Lafora progressive myoclonus epilepsy. Mitra S; Chen B; Wang P; Chown EE; Dear M; Guisso DR; Mariam U; Wu J; Gumusgoz E; Minassian BA Dis Model Mech; 2023 Jan; 16(1):. PubMed ID: 36511140 [TBL] [Abstract][Full Text] [Related]
23. Lafora progressive myoclonus epilepsy: recent insights into cell degeneration. Spuch C; Ortolano S; Navarro C Recent Pat Endocr Metab Immune Drug Discov; 2012 May; 6(2):99-107. PubMed ID: 22369717 [TBL] [Abstract][Full Text] [Related]
24. Increased laforin and laforin binding to glycogen underlie Lafora body formation in malin-deficient Lafora disease. Tiberia E; Turnbull J; Wang T; Ruggieri A; Zhao XC; Pencea N; Israelian J; Wang Y; Ackerley CA; Wang P; Liu Y; Minassian BA J Biol Chem; 2012 Jul; 287(30):25650-9. PubMed ID: 22669944 [TBL] [Abstract][Full Text] [Related]
25. Suppression of leptin signaling reduces polyglucosan inclusions and seizure susceptibility in a mouse model for Lafora disease. Rai A; Mishra R; Ganesh S Hum Mol Genet; 2017 Dec; 26(24):4778-4785. PubMed ID: 28973665 [TBL] [Abstract][Full Text] [Related]
31. Increased endoplasmic reticulum stress and decreased proteasomal function in lafora disease models lacking the phosphatase laforin. Vernia S; Rubio T; Heredia M; Rodríguez de Córdoba S; Sanz P PLoS One; 2009 Jun; 4(6):e5907. PubMed ID: 19529779 [TBL] [Abstract][Full Text] [Related]
32. Identification and characterization of novel splice variants of the human EPM2A gene mutated in Lafora progressive myoclonus epilepsy. Dubey D; Parihar R; Ganesh S Genomics; 2012 Jan; 99(1):36-43. PubMed ID: 22036712 [TBL] [Abstract][Full Text] [Related]
33. Lafora disease ubiquitin ligase malin promotes proteasomal degradation of neuronatin and regulates glycogen synthesis. Sharma J; Rao SN; Shankar SK; Satishchandra P; Jana NR Neurobiol Dis; 2011 Oct; 44(1):133-41. PubMed ID: 21742036 [TBL] [Abstract][Full Text] [Related]
34. The laforin-malin complex, involved in Lafora disease, promotes the incorporation of K63-linked ubiquitin chains into AMP-activated protein kinase beta subunits. Moreno D; Towler MC; Hardie DG; Knecht E; Sanz P Mol Biol Cell; 2010 Aug; 21(15):2578-88. PubMed ID: 20534808 [TBL] [Abstract][Full Text] [Related]
35. Ubiquitin conjugating enzyme E2-N and sequestosome-1 (p62) are components of the ubiquitination process mediated by the malin-laforin E3-ubiquitin ligase complex. Sánchez-Martín P; Romá-Mateo C; Viana R; Sanz P Int J Biochem Cell Biol; 2015 Dec; 69():204-14. PubMed ID: 26546463 [TBL] [Abstract][Full Text] [Related]
36. Oxidative stress, a new hallmark in the pathophysiology of Lafora progressive myoclonus epilepsy. Romá-Mateo C; Aguado C; García-Giménez JL; Knecht E; Sanz P; Pallardó FV Free Radic Biol Med; 2015 Nov; 88(Pt A):30-41. PubMed ID: 25680286 [TBL] [Abstract][Full Text] [Related]
37. Pathogenesis of Lafora Disease: Transition of Soluble Glycogen to Insoluble Polyglucosan. Sullivan MA; Nitschke S; Steup M; Minassian BA; Nitschke F Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28800070 [TBL] [Abstract][Full Text] [Related]
38. Lafora disease: Current biology and therapeutic approaches. Mitra S; Gumusgoz E; Minassian BA Rev Neurol (Paris); 2022 Apr; 178(4):315-325. PubMed ID: 34301405 [TBL] [Abstract][Full Text] [Related]
39. Laforin, a dual specificity phosphatase involved in Lafora disease, is present mainly as monomeric form with full phosphatase activity. Dukhande VV; Rogers DM; Romá-Mateo C; Donderis J; Marina A; Taylor AO; Sanz P; Gentry MS PLoS One; 2011; 6(8):e24040. PubMed ID: 21887368 [TBL] [Abstract][Full Text] [Related]
40. Recent advances in the molecular basis of Lafora's progressive myoclonus epilepsy. Ganesh S; Puri R; Singh S; Mittal S; Dubey D J Hum Genet; 2006; 51(1):1-8. PubMed ID: 16311711 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]